TTC32 divergent transcript (TTC32-DT)

The **TTC32 divergent transcript** is a long non-coding RNA produced by *divergent transcription* at or near the promoter region of the TTC32 gene. Divergent transcripts arise when transcription starts from both directions of a promoter, generating an RNA on the opposite strand from the protein-coding gene. These transcripts are typically short, expressed at low levels, and mainly remain associated with chromatin rather than being exported to the cytoplasm. While some divergent lncRNAs regulate nearby protein-coding genes or participate in chromatin and transcriptional dynamics, there is no current evidence that TTC32-DT has a clear biological function, is associated with disease, or serves as a target for therapy. **TTC32-DT is not an established therapeutic target, and its listing as such is likely incorrect**. Additional context: - The term "divergent transcript" in this context describes the transcript's mode of origin (from bidirectional promoter activity) rather than a specific biological activity, receptor, or protein function. - Many lncRNAs produced by divergent transcription are poorly characterized, and their cellular functions, if any, are largely speculative or not fully understood. Summary: TTC32-DT is a divergent long non-coding RNA with no established therapeutic relevance, mechanism, or biomarker status. Its inclusion as a target is likely *incorrect*, and it should not be considered a canonical receptor, enzyme, or other structured drug target.

Other names

TTC32-DTTTC32 divergent transcript